Jennifer Canez
Family · Tucson, AZNPI 1265934939
Payments from drug & device makers
Across 127 payments — averaging $39.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$714
- Edwards Lifesciences$508
- Novo Nordisk$335
- Pfizer$329
- Novartis$295
- Johnson & Johnson$233
- plus $3K from 27 others
What the payments were for
- Food & beverage$4,994100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $714 |
| Edwards Lifesciences | 9 | $508 |
| Novo Nordisk | 6 | $335 |
| Pfizer | 19 | $329 |
| Novartis | 18 | $295 |
| Johnson & Johnson | 8 | $233 |
| Boehringer Ingelheim | 3 | $229 |
| Abbott | 8 | $219 |
| Medtronic | 2 | $194 |
| Actelion Pharmaceuticals US, Inc. | 3 | $173 |
| Vantive US Healthcare LLC | 1 | $149 |
| Scpharmaceuticals Inc. | 2 | $142 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $128 |
| Revance Therapeutics, Inc. | 1 | $126 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Genentech USA, Inc. | 1 | $125 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $110 |
| Nevro Corp. | 1 | $104 |
| Boston Scientific | 4 | $96 |
| Esperion Therapeutics, Inc. | 5 | $87 |
| Gilead | 1 | $86 |
| Lexicon Pharmaceuticals, Inc. | 4 | $85 |
| Amgen | 4 | $77 |
| Baxter Healthcare | 1 | $69 |
| Tactile Systems Technology Inc | 1 | $66 |
| Biosense Webster, Inc. | 2 | $35 |
| Cvrx, Inc. | 1 | $29 |
| Akebia Therapeutics Inc | 1 | $28 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $28 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Apellis Pharmaceuticals, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,994 in reported general payments places this provider in the 90th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 175 | $267,023 |
| JardianceEmpagliflozin | 47 | $65,117 |
| XareltoRivaroxaban | 37 | $38,137 |
| FarxigaDapagliflozin Propanediol | 24 | $38,111 |
| EntrestoSacubitril/Valsartan | 13 | $22,883 |
| Repatha SureclickEvolocumab | 15 | $20,425 |
| NexletolBempedoic Acid | 14 | $10,801 |
| Ranolazine ErRanolazine | 43 | $6,007 |
| Nebivolol Hcl | 78 | $4,622 |
| Rosuvastatin Calcium | 360 | $4,083 |
| Telmisartan | 120 | $2,640 |
| Famotidine | 107 | $1,856 |
| Flecainide Acetate | 15 | $1,491 |
| Losartan Potassium | 118 | $1,287 |
| Diltiazem Hcl | 40 | $1,248 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $329 | $267,023175 claims |
| Boehringer IngelheimJardiance | $229 | $65,11747 claims |
| Johnson & JohnsonXarelto | $233 | $38,13737 claims |
| AstraZenecaFarxiga | $714 | $38,11124 claims |
| NovartisEntresto | $295 | $22,88313 claims |
| Esperion Therapeutics, Inc.Nexletol | $87 | $10,80114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,119 family providers in Arizona.
Other family in Tucson
- Lindsay CarterTucson$108K
- Vicki McIntyreTucson$68K
- Amber KemnitzTucson$33K
- Joy BaynesTucson$30K
- Cynthia CarstenTucson$27K
- Sharon MorganTucson$22K
- Margaret SpencerTucson$19K
- Polina SamoylovaTucson$18K
- Stephanie Niemi-OlsonTucson$15K
- Cindy ChangTucson$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.